SEC Form 4 · accession 0001288123-17-000014
AGENUS INC · AGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garo H Armen
Officer — Chairman and CEO
Period of report
Mar 31, 2017
Accepted (ET)
Apr 4, 2017 · 6:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001098972
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | — | Mar 31, 2017 | A | 647,000 | A | Mar 31, 2022 | Mar 31, 2022 | Common Stock | 647,000 | 647,000 | D |
| Stock Option, Right to BuyF2 | $3.77 | Mar 31, 2017 | A | 853,000 | A | Mar 31, 2022 | Mar 31, 2027 | Common Stock | 853,000 | 853,000 | D |
Explanation of responses
- F1Award vests on March 31, 2022 if and only if the 20-day average closing price of the Company's common stock on March 31, 2022 is greater than or equal to $15 per share provided Dr. Armen maintains a service relationship with the Company at all times through such date.
- F2Option vests 100% on 5-year anniversary of the award provided Dr. Armen maintains a service relationship with the Company on such date.